Concepedia

Dong Wang

DW

Statistics

Publications

5

Citations

166

H-Index

5

Active since

2015

Affiliations

University of Science and Technology Beijing(Current)

Guiyang Medical University

Kanazawa University

Daping Hospital

Ningxia Medical University

Dong Wang is an author at University of Science and Technology Beijing specializing in cancer cell signaling, molecular oncology, and oncogenic signaling pathways.

ORCID

Publications per year

2015–2024

5

Publications

5

Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells

Shu-Feng Zhou, Chunxiu Yuan, Zhi-Wei Zhou et al. · Drug Design Development and Therapy · 2015 · 47 citations · Full text

, , +17

Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells

Shu‐Feng Zhou, Shuting Pan, Yiru Qin et al. · Drug Design Development and Therapy · 2015 · 42 citations · Full text

, , +17

Characterization of <scp><i>RNF43</i></scp> frameshift mutations that drive <scp>Wnt</scp> ligand‐ and <scp>R</scp>‐spondin‐dependent colon cancer

Daisuke Yamamoto, Hiroko Oshima, Dong Wang et al. · The Journal of Pathology · 2022 · 38 citations · Full text

, , +17

Gain-of-Function p53 Mutation Acts as a Genetic Switch for TGFβ Signaling–Induced Epithelial-to-Mesenchymal Transition in Intestinal Tumors

Dong Wang, Mizuho Nakayama, Chang Pyo Hong et al. · Cancer Research · 2023 · 25 citations · Full text

, , +17

Precise Regulation of Reactive Oxygen Species in Tumor Microenvironment for Alleviating Inhibitory Immunogenic Cell Death

Zichuang Xu, Yuchu He, Xuwu Zhang et al. · Advanced Healthcare Materials · 2024 · 14 citations · Full text

, , +17

1–5 of 5